Stocktoria
Aprea Therapeutics, Inc. APRE
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2019-10-03
Aprea Therapeutics, Inc. statistics & valuation
Market cap$9.8M
P / B0.8×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -79.1% | -54.0% | -63.1% | -373.6% | -65.3% |
| Return on equity | -101.3% | -67.1% | -84.3% | -439.3% | -75.0% |
| Current ratio | 5.63 | 7.01 | 5.14 | 9.42 | 7.73 |
Source: SEC EDGAR filings · CIK 0001781983 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.